Event

Jonathan Corren

MD
David Geffen School of Medicine at UCLA

Neil M.H. Graham

MD, MPH, MBBS
Regeneron Pharmaceuticals, Inc.

Bingzhi Zhang

PhD
Sanofi

J Mark FitzGerald

MB, MD, FRCPC
Department of Medicine (Division of Respiratory Medicine) - University of British Columbia;Gordon & Leslie Diamond Health Care Ctr;University of British Columbia

Nikhil Amin

MD
Regeneron Pharmaceuticals, Inc.

Yuji Tohda

M.D., Ph.D.
Kindai University Faculty of Medicine;Kindai University, Faculty of Medicine

Marcella Ruddy

MD
Regeneron Pharmaceuticals, Inc.

Bolanle Akinlade

MD, MBA
Regeneron Pharmaceuticals, Inc.

Heribert Staudinger

MD, PhD
Sanofi

William W. Busse

MD
Univ of Wisconsin Hosp;University of Wisconsin;University of Wisconsin Hospital;University of Wisconsin School of Medicine and Public Health

Linda B. Ford

MD
Asthma and Allergy Center

Lawrence Sher

MD
Penninsula Research Associates,

Renata Martincova

MD
Sanofi

Gianluca Pirozzi

MD, PhD
Sanofi

Jorge F. Maspero

MD
Fundación CIDEA

Jingdong Chao

PharmD
Regeneron Pharmaceuticals, Inc.

Constance Katelaris

MB BS PhD FRACP
Campbelltown Hospital and Western Sydney University

Ian Pavord

MD, DM
Nuffield Department of Medicine and Oxford NIHR BRC, University of Oxford;Oxford University Hospitals NHS Foundation Trust;University of Oxford

Sally E. Wenzel

MD
Univ of Pittsburgh Med Ctr;Universirty of Pittsburgh;University of Pittsburgh;University of Pittsburgh Medical Center

Asif Khan

MD, MPH
Sanofi

Ariel Teper

MD
Sanofi

Mario Castro

MD, MPH
Washington Univ Sch of Med;Washington University School of Medicine

Klaus F. Rabe

Pulmonary Medicine
LungClinic Grosshansdorf;LungenClinic Grosshansdorf;LungenClinic Grosshansdorf and Christian Albrechts University;LungenClinic Grosshansdorf and Christian-Albrechts University, Kiel, Airway Research C

A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and Safety of Dupilumab in Uncontrolled Moderate-to-Severe Asthma